Please wait while the formulary information is being retrieved.
LOVAZA (omega-3 acid ethyl esters)
- high amount of triglyceride in the blood
1 gram capsule
- 2 capsules (2 gram) by oral route 2 times per day
1 gram capsule
- 2 capsules (2 gram) by oral route 2 times per day
Default screening record
- 2 capsules (2 gram) by oral route 2 times per day
- 4 capsules (4 gram) by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Abnormal hepatic function tests
- Atrial fibrillation
- Disease of liver
LOVAZA (omega-3 acid ethyl esters)
- high amount of triglyceride in the blood
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysgeusia
- Dyspepsia
- Eructation
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
Less Severe
- Abnormal hepatic function tests
- Constipation
- Pruritus of skin
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Omega-3 Acids Ethyl Esters
- Severity Level:
2
- Additional Notes: Insuff human data; consider maternal benefit
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Omega-3 Acid Ethyl Esters
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hypertriglyceridemia | |
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
| 0-9 | A-Z |
|---|---|
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
Formulary Reference Tool